| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 45, 768-774, Copyright © 1977 by Endocrine Society
ARTICLES |
JJ Nordlund and AB Lerner
We studied the effects of prolonged ingestion of melatonin, 1 g per day, on skin color and the serum levels of pituitary hormones in 5 human subjects with hyperpigmented skin. Melatonin lightened hyperpigmented skin of one patient with untreated adrenogenital syndrome, but had no effect on three patients' skin with idiopathic hyperpigmentation and one patient with treated Addison's disease. Melatonin appeared to depress the level of luteinizing hormone (LH) in serum and may have inhibited in some patients the release of growth hormone from the pituitary gland after stimulation by stress or L-dopa. The subjects all noted increased drowsiness but through studies on the eyes, liver, kidneys, and bone marrow revealed no other evidence of toxicity.
This article has been cited by other articles:
![]() |
T. Lialiaris, E. Lyratzopoulos, F. Papachristou, M. Simopoulou, C. Mourelatos, and N. Nikolettos Supplementation of melatonin protects human lymphocytes in vitro from the genotoxic activity of melphalan Mutagenesis, September 1, 2008; 23(5): 347 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Slominski, J. Wortsman, and D. J. Tobin The cutaneous serotoninergic/melatoninergic system: securing a place under the sun FASEB J, February 1, 2005; 19(2): 176 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Reiter, D.-x. Tan, J. Leon, U. Kilic, and E. Kilic When Melatonin Gets on Your Nerves: Its Beneficial Actions in Experimental Models of Stroke Experimental Biology and Medicine, February 1, 2005; 230(2): 104 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Slominski, D. J. Tobin, S. Shibahara, and J. Wortsman Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation Physiol Rev, October 1, 2004; 84(4): 1155 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
A W Siu, G G Ortiz, G Benitez-King, C H To, and R J Reiter Effects of melatonin on the nitric oxide treated retina Br. J. Ophthalmol., August 1, 2004; 88(8): 1078 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
Vijayalaxmi, C. R. Thomas Jr, R. J. Reiter, and T. S. Herman Melatonin: From Basic Research to Cancer Treatment Clinics J. Clin. Oncol., May 15, 2002; 20(10): 2575 - 2601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Karbownik and R. J. Reiter Antioxidative Effects of Melatonin in Protection Against Cellular Damage Caused by Ionizing Radiation Experimental Biology and Medicine, October 1, 2000; 225(1): 9 - 22. [Abstract] [Full Text] |
||||
![]() |
R. Luboshitzky, M. Levi, Z. Shen-Orr, Z. Blumenfeld, P. Herer, and P. Lavie Long-term melatonin administration does not alter pituitary-gonadal hormone secretion in normal men Hum. Reprod., January 1, 2000; 15(1): 60 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Van Den Heuvel, D. J. Kennaway, and D. Dawson Effects of daytime melatonin infusion in young adults Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E19 - E26. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pappolla, P. Bozner, C. Soto, H. Shao, N. K. Robakis, M. Zagorski, B. Frangione, and J. Ghiso Inhibition of Alzheimer beta -Fibrillogenesis by Melatonin J. Biol. Chem., March 27, 1998; 273(13): 7185 - 7188. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brzezinski Melatonin in Humans N. Engl. J. Med., January 16, 1997; 336(3): 186 - 195. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |